Giovannoni G, Rammohan K, Cook S, et al. Proportions of patients with highly active RMS achieving no evidence of disease activity (NEDA) in response to cladribine tablets in CLARITY. ECTRIMS 217, P1143.
Heterogeniteit in de ziekte van Alzheimer – een data-gedreven benadering
apr 2020 | Dementie